Plasma oxysterol levels in luminal subtype breast cancer patients are associated with clinical data

par Kloudova-Spalenkova, Alzbeta, Ueng, Yune-Fang, Wei, Shouzou, Kopeckova, Katerina, Guengerich, F. Peter, Soucek, Pavel
Publié dans J Steroid Biochem Mol Biol (2019)

Role of Genetic Variation in ABC Transporters in Breast Cancer Prognosis and Therapy Response

par Hlaváč, Viktor, Václavíková, Radka, Brynychová, Veronika, Koževnikovová, Renata, Kopečková, Katerina, Vrána, David, Gatěk, Jiří, Souček, Pavel
Publié dans Int J Mol Sci (2020)

Role of Genetic Variation in Cytochromes P450 in Breast Cancer Prognosis and Therapy Response

par Hlaváč, Viktor, Václavíková, Radka, Brynychová, Veronika, Ostašov, Pavel, Koževnikovová, Renata, Kopečková, Katerina, Vrána, David, Gatěk, Jiří, Souček, Pavel
Publié dans Int J Mol Sci (2021)

Cytochrome b(5) plays a dual role in the reaction cycle of cytochrome P450 3A4 during oxidation of the anticancer drug ellipticine

par Stiborová, Marie, Indra, Radek, Frei, Eva, Kopečková, Kateřina, Schmeiser, Heinz H., Eckschlager, Tomáš, Adam, Vojtěch, Heger, Zbyněk, Arlt, Volker M., Martínek, Václav
Publié dans Monatsh Chem (2017)

Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Anal...

par Fiala, Ondrej, Finek, Jindrich, Poprach, Alexandr, Melichar, Bohuslav, Kopecký, Jindrich, Zemanova, Milada, Kopeckova, Katerina, Mlcoch, Tomas, Dolezal, Tomas, Capkova, Lenka, Buchler, Tomas
Publié dans Cancers (Basel) (2020)

Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation

par Indra, Radek, Pompach, Petr, Martínek, Václav, Takácsová, Paulína, Vavrová, Katarína, Heger, Zbyněk, Adam, Vojtěch, Eckschlager, Tomáš, Kopečková, Kateřina, Arlt, Volker Manfred, Stiborová, Marie
Publié dans Int J Mol Sci (2019)

Use of Germline Genetic Variability for Prediction of Chemoresistance and Prognosis of Breast Cancer Patients

par Hlavac, Viktor, Kovacova, Maria, Elsnerova, Katerina, Brynychova, Veronika, Kozevnikovova, Renata, Raus, Karel, Kopeckova, Katerina, Mestakova, Sona, Vrana, David, Gatek, Jiri, Ostasov, Pavel, Vaclavikova, Radka, Soucek, Pavel
Publié dans Cancers (Basel) (2018)

Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry

par Poprach, Alexandr, Holanek, Milos, Chloupkova, Renata, Lakomy, Radek, Stanik, Michal, Fiala, Ondrej, Melichar, Bohuslav, Kopeckova, Katerina, Zemanova, Milada, Kiss, Igor, Penka, Igor, Bohosova, Julia, Buchler, Tomas
Publié dans Cancers (Basel) (2020)

Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis

par Buchler, Tomas, Chloupkova, Renata, Poprach, Alexandr, Fiala, Ondrej, Kiss, Igor, Kopeckova, Katerina, Dusek, Ladislav, Veskrnova, Veronika, Slavicek, Lubomir, Kohoutek, Milan, Finek, Jindrich, Svoboda, Marek, Petruzelka, Lubos, Melichar, Bohuslav
Publié dans Cancer Manag Res (2018)

Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 Patients

par Novakova-Jiresova, Alena, Kopeckova, Katerina, Boublikova, Ludmila, Chloupkova, Renata, Melichar, Bohuslav, Petruzelka, Lubos, Finek, Jindrich, Fiala, Ondrej, Grell, Peter, Batko, Stanislav, Linke, Zdenek, Kiss, Igor, Prausova, Jana, Buchler, Tomas
Publié dans Cancer Manag Res (2020)

Expenditures on Oncology Drugs and Cancer Mortality‐to‐Incidence Ratio in Central and Eastern Europe

par Vrdoljak, Eduard, Bodoky, Gyorgy, Jassem, Jacek, Popescu, Razvan, Pirker, Robert, Čufer, Tanja, Bešlija, Semir, Eniu, Alexandru, Todorović, Vladimir, Kopečková, Katerina, Kurteva, Galia, Tomašević, Zorica, Sallaku, Agim, Smichkoska, Snezhana, Bajić, Žarko, Sikic, Branimir
Publié dans Oncologist (2018)

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry

par Lakomy, Radek, Poprach, Alexandr, Bortlicek, Zbynek, Melichar, Bohuslav, Chloupkova, Renata, Vyzula, Rostislav, Zemanova, Milada, Kopeckova, Katerina, Svoboda, Marek, Slaby, Ondrej, Kiss, Igor, Studentova, Hana, Juracek, Jaroslav, Fiala, Ondrej, Kopecky, Jindrich, Finek, Jindrich, Dusek, Ladislav, Hejduk, Karel, Buchler, Tomas
Publié dans BMC Cancer (2017)

Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment

par Rolfo, Christian, Isambert, Nicolas, Italiano, Antoine, Molife, L. Rhoda, Schellens, Jan H.M., Blay, Jean‐Yves, Decaens, Thomas, Kristeleit, Rebecca, Rosmorduc, Olivier, Demlova, Regina, Lee, Myung‐Ah, Ravaud, Alain, Kopeckova, Katerina, Learoyd, Maria, Bannister, Wendy, Locker, Gershon, de Vos‐Geelen, Judith
Publié dans Br J Clin Pharmacol (2020)

Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study

par Chau, Ian, Park, Joon Oh, Ryoo, Baek-Yeol, Yen, Chia-Jui, Poon, Ronnie, Pastorelli, Davide, Blanc, Jean-Frédéric, Kudo, Masatoshi, Pfiffer, Tulio, Hatano, Etsuro, Chung, Hyun Cheol, Kopeckova, Katerina, Phelip, Jean-Marc, Brandi, Giovanni, Ohkawa, Shinichi, Li, Chung-Pin, Okusaka, Takuji, Hsu, Yanzhi, Abada, Paolo B., Zhu, Andrew X.
Publié dans Br J Cancer (2018)